Post by healthy11 on Apr 15, 2013 20:33:11 GMT -5
“The approval of Quillivant XR fills a void that has long existed in the treatment of ADHD,” said Ann Childress, M.D., president of the Center for Psychiatry and Behavioral Medicine, Las Vegas, who was an investigator in the Quillivant XR laboratory classroom study.
“We routinely see the struggles of patients who have difficulty swallowing pills or capsules. Having the option of a once-daily liquid will help alleviate some of these issues while still providing the proven efficacy of methylphenidate for 12 hours after dosing.”
There's more info at psychcentral.com/news/2012/10/03/fda-oks-extended-release-liquid-adhd-medication-quillivant/45469.html
“We routinely see the struggles of patients who have difficulty swallowing pills or capsules. Having the option of a once-daily liquid will help alleviate some of these issues while still providing the proven efficacy of methylphenidate for 12 hours after dosing.”
There's more info at psychcentral.com/news/2012/10/03/fda-oks-extended-release-liquid-adhd-medication-quillivant/45469.html